Sources | Names Used |
---|---|
CTRPv2 | BRD-K03536150 |
PharmacoGx | BRD-K03536150 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RASGEF1B | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | TCF3 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | OR13A1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | EPM2A | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
mRNA | PAX5 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | ZNF273 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
mRNA | ZNF138 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-09 |